Synaptics Incorporated <SYNA.O>: Rosenblatt Securities cuts target price to $115 from $160
SYNA•Related News
AN2 Therapeutics grants CMO Cameron Trenor options for 233,333 shares at USD 5.36 each
ANTX•
Greenlight Capital Re director Ian Isaacs sells 4,850 shares for $73,357.71
GLRE•
Netflix's 'Monsters' explores Lizzie Borden mystery in first female-focused season
NFLX•
Fox Executive Chair, CEO Lachlan K. Murdoch disposes of 149,934 Fox shares worth $10.28 million
FOXA•
DataMeds AI buys Helomics cancer diagnostics lab from Axe Compute for USD 1.5 million
MEDS•